Price $97.17 |
Market Cap
3B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.88
|
P/S
1.34
|
Dividend %
-
|
|
P/CF
47.7
|
P/FCF
26.7
|
Op. Cash Flow
117.8K
|
FCF
3.4
|
|
Op. Margin
2.80%
|
Net Margin
0.10%
|
ROE
0.30%
|
ROI
9.30%
|
|
ROA
0.10%
|
EPS Growth
-97.80%
|
Current Ratio
1.1
|
Debt/Equity
39.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| CordovaCann Corp (LVRLF) | $0.06 | - | - | 12.6M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
